Neurodermatitis clinical trials
The registry lists 33 studies for Neurodermatitis across more than 10 countries. 6 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-09-22.
Status
- Completed
- 24
- Not yet recruiting
- 4
- Status unknown
- 3
- Recruiting
- 2
Phase
- Phase 3
- 14
- Phase 2
- 8
- Phase 1
- 5
- Phase 4
- 2
Where
- United States
- 14
- Germany
- 12
- China
- 9
- Poland
- 6
- Canada
- 5
- Hungary
- 4
Who runs them
Sanofi (4) · Galderma R&D (3) · Vyne Therapeutics Inc. (3) · Cairo University (2) · Prime Gene Therapeutics Co., Ltd. (2) · Second Affiliated Hospital, School of Medicine, Zhejiang University (2) · Trevi Therapeutics (2) · Kamari Pharma Ltd (1)
Studies
Recruiting first, then most recently updated. Showing 33 of 33 — search for more.
- A Phase I Clinical Trial to Evaluate the Single Dose Ascending and Food Effects of PG-033 in Healthy AdultsRecruitingNCT07013097Phase 11 country
- A Study to Evaluate the Multiple Dose Ascending of PG-033 in Healthy Adult Participants.Not yet recruitingNCT07619183Phase 11 country
- Phase III Clinical Study of MG-K10 Humanized Mab Injection in Subjects With Prurigo NodularisRecruitingNCT06779136Phase 31 country
- A Randomized, Double-blinded, Self-controlled Clinical Study of Intralesional Injection of 5-fluorouracil Plus Triamcinolone for the Treatment of Refractory Nodular PrurigoNot yet recruitingNCT06524323Phase 31 country
- Efficacy and Safety of Tofacitinib in Patients With Prurigo NodularisNot yet recruitingNCT06201715Not applicable1 country
- Fractional Carbon Dioxide Laser: A Novel Therapeutic Option for Lichen Simplex ChronicusNot yet recruitingNCT06267066Not applicable1 country
- Efficacy and Safety of HA35 Gel for Ultra-Rapid Skin Pruritus ReliefCompletedNCT07580911Not applicable1 country
- A Study to Investigate Improvement in Pruritus of Lichen Simplex Chronicus With Dupilumab Injections Compared With Placebo in Male and Female Participants Aged at Least 18 Years (STYLE 2)CompletedNCT06687980Phase 317 countries
- A Study to Investigate Improvement in Pruritus of Lichen Simplex Chronicus With Dupilumab Injections Compared With Placebo in Male and Female Participants Aged at Least 18 Years (STYLE 1)CompletedNCT06687967Phase 317 countries
- Effect of Extracorporeal Shockwave Therapy on Pruritus in Neurodermatitis PatientsCompletedNCT07206680Not applicable1 country
- Study of Dupilumab for the Treatment of Patients With Prurigo Nodularis, Inadequately Controlled on Topical Prescription Therapies or When Those Therapies Are Not Advisable (LIBERTY-PN PRIME)CompletedNCT04183335Phase 38 countries
- Study of Dupilumab for the Treatment of Patients With Prurigo Nodularis, Inadequately Controlled on Topical Prescription Therapies or When Those Therapies Are Not Advisable (PRIME2)CompletedNCT04202679Phase 311 countries
- Study of Nalbuphine HCl ER Tablets in Patients With Prurigo NodularisCompletedNCT02174419Phase 2/33 countries
- Open Label Extension Study of Nalbuphine HCl ER in Patients With Prurigo NodularisCompletedNCT02174432Phase 2/31 country
- A Study to Assess the Efficacy, Safety, and Tolerability of KPL-716 in Reducing Pruritus in Chronic Pruritic DiseasesCompletedNCT03858634Phase 21 country
- A Study to Evaluate the Durability of Response and Safety of Nemolizumab for 24 Weeks in Participants With Prurigo NodularisCompletedNCT05052983Phase 37 countries
- Study to Assess the Efficacy and Safety of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN)CompletedNCT04501666Phase 310 countries
- A Study to Assess the Efficacy and Safety of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN)CompletedNCT04501679Phase 39 countries
- KM-001 Cream for Treatment of Pruritus in Adult Patients With Lichen Simplex Chronicus (LSC)CompletedNCT05454462Phase 11 country
- A Study of CDX-0159 in Patients With Prurigo NodularisCompletedNCT04944862Phase 13 countries
- Efficacy of Abrocitinib for Reducing Pruritus in Adults With Prurigo Nodularis and Chronic Pruritus of Unknown OriginCompletedNCT05038982Phase 21 country
- Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Prurigo NodularisCompletedNCT03677401Phase 33 countries
- A Randomized Placebo-Controlled Study of the Neurokinin-1 (NK1) Receptor Antagonist Serlopitant Prurigo Nodularis (PN)CompletedNCT02196324Phase 21 country
- Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Prurigo NodularisCompletedNCT03546816Phase 31 country
- Investigation of Efficacy of Secukinumab in Patients With Moderate to Serve Atopic DermatitisCompletedNCT03568136Phase 21 country
- Pain Outcomes Following Intralesional Corticosteroid InjectionsCompletedNCT03630198Phase 41 country
- Transcriptomic Landscape of T Lymphocytes of Atopic Dermatitis, Atopic Prurigo Nodularis (of Besnier) and Non-atopic Prurigo Nodularis (of Hyde) Using Single Cell RNA-sequencingStatus unknownNCT04681300
- Diagnostic Accuracy of "Three Rings Vulvoscopy" for Detection of Vulvar DermatosisCompletedNCT02732145Not applicable1 country
- Apremilast as Anti-pruritic Treatment in Patients With Prurigo NodularisStatus unknownNCT03576287Phase 1/21 country
- Safety and Efficacy of CC-10004 for Prurigo NodularisCompletedNCT00869089Phase 21 country
- Investigation of Efficacy and Safety of EPOGAMCompletedNCT00878670Phase 41 country
- Effectiveness of the Selective Serotonin Reuptake Inhibitor,Citalopram (Cipralex), in Prurigo NodularisStatus unknownNCT00532519Not applicable1 country
- Study About Effectiveness of Silver-Containing Textiles for Treatment of Acute NeurodermatitisCompletedNCT00196430Phase 31 country